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ABSTRACT 
 
In systems with several effectors, the results of dose-response (DR) experiments are usually 
assessed by checking them against two hypotheses: independent action (IA) and concentration 
addition (CA). Both are useful simplifications, but do not represent the only possible 
responses, and avoid to a large extent the analysis of the interactions that are possible in the 
system. In addition, these are often applied in such a way that they produce insufficient 
descriptions of the problem that raises them, frequent inconclusive cases and doubtful 
decisions. In this work a generative approach is attempted, starting from some simple 
mechanisms that shows the response of an elementary biological entity to an effector agent. A 
set of simulations is formulated next through an equally simple system of logical rules, and 
several families of virtual responses are thus generated. These families include typical 
responses of IA and CA modes of action, other ones not less probable from a physiological 
point of view, and even other derived from common and expectable forms of interactions. The 
analysis of these responses enabled, firstly, to relate some phenomenological regularities with 
some general mechanistic principles, and to detect several causes by which the IA-CA 
dualism is necessarily ambiguous. Secondly, it allowed to identify different forms of synergy 
and antagonism that contribute to explain some controversial aspects of these notions. Finally, 
it led to propose two sets of explicit algebraic equations which describe accurately a wide 
diversity of possible and realistic responses. 
 
1. INTRODUCTION 
 
The response of a population of biological entities to the action of an effector is typically 
sigmoidal and requires for its algebraic description (the dose-response model: DR) an 
equation with at least three parameters. If the response is altered by a perturbation agent, 
variations depending on the perturbator concentration must be expected in one or more of 
these parameters. If two effectors interact, one or more parameters corresponding to the action 
of each effector will vary, in the description of the joint response, as a function of the 
concentration of the other one. Although these premises are not much debatable, their 
practical application has the disadvantage of requiring a solution whose complexity increases 
in a more than linear way with the number of effectors considered. 
 
This justifies the common use of two simplifications: the IA (independent action) [1] and the 
CA (concentration addition) [2,3] hypotheses. Both avoid the mentioned disadvantage by 
postulating conditions that allow verifiable predictions about the joint response, using the 
individual DR models without adding new parameters. Next, we will point out that their 
formalizations are generally considered as empiric models lacking in mechanistic content –
which in our opinion is not completely true- and afterwards we will discuss the details of the 
IA ans CA hypotheses. 
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DR models are considered empirical (phenomenological, macroscopical) because they are 
descriptions whose reference is the distribution of the sensitivity to an effector in a target 
population. Although this provides them a statistical basis, ultimately the response depends on 
processes that take place at the level of the interactions between the effector quanta (ions, 
atoms, molecules, electric pulses, radiations) and the receptor structures of the biological 
system, a level that is ignored by the model. However, using a thermodynamic analogy, the 
(macroscopic) sensitivity distribution can be broken down into the (microscopic) distributions 
of other elements that are response-determining at a finer resolution level. These elements can 
be physical structures whose reduction to other simpler ones has no sense (as the number of 
receptors per biological entity), or more complex physiological limits (as a response 
threshold). In any case, they can be put in connection with the quanta of the effector agent 
through hypotheses of some general forms of molecular interaction in biological systems. 
 
Under this perspective, IA and CA hypotheses postulate modes of action, that is, they can be 
associated to general mechanisms or microscopic conditions that allow to propose variations 
capable of generating specific responses. To classify these variations from bibliographical 
experimental results is difficult because: the interference of the experimental error; the 
required categories are not usually considered in toxicodynamic studies; and the suitable 
designs for a given hypothesis rarely can be used to prove facts outside their conceptual 
frameworks. A way for eluding these difficulties is the use of simulation “experiments”. Both 
the statistical basis and the general types of mechanisms underlying the DR relationships 
(interactions between cell receptors, effectors and interfering agents) are sufficiently known 
for simulating microscopic conditions able to produce the corresponding macroscopic 
(population) results. 
 
In the simulations used in this work, simple properties for the microscopic determinants of the 
response were postulated, and a set of basic “sigmoidal scenes” –among them those 
associated with IA and CA hypotheses– were generated with the only assistance of logical 
(Boolean) rules. Additionally, more specific response surfaces were obtained by including in 
such rules some algebraic expressions describing concrete interactions as those that can take 
place in many physiological contexts (activation/deactivation, competence/cooperation, steric 
hindrance). The results allowed to illustrate the status of IA and CA hypotheses within the 
field of the possible responses, to characterize several types of perturbations and interactions, 
and to propose explicit algebraic models that translate the mechanics of the response into 
specific parametric variations. Although in some cases the practical utility of these models 
can be limited by a low number of observations and a high experimental error, the simulations 
constitute always a useful reference for interpreting a complex response, inferring the type of 
mechanism involved and suggesting complementary experiments. 
 
2. MATERIAL AND METHODS 
 
2.1. Numerical methods 
 
Hereafter we will call effector any agent able to cause a (typically sigmoidal) response in a 
population of biological entities, and perturbator to any agent that can alter the response to an 
effector, itself being unable to cause it. Receptor is any biological structure acting as ligand of 
effector or perturbator. The term dose is reserved to the concentration of an effector. 
 
In the simulation procedures that are described later, the Weibull’s random numbers w:(θ;α) 
were obtained, from the uniform random numbers u:[0,1] provided by the spreadsheet, 
through [4,5]: 
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where mean (µw) and standard deviation (σw) of the corresponding distribution are: 
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To facilitate comparisons, doses were coded into the [0-(0.1)-1] interval, and responses were 
calculated by establishing that when of a total number Y of biological entities, S survive at a 
given dose, the population response is R=1–(S/Y). Simulated and experimental results were 
adjusted to the proposed models by non-linear least squares methods (quasi-Newton), in 
Microsoft Excel spreadsheet, using Solver complement for parametric estimates, and Solver 
Aid macro [6,7] for confidence intervals and model consistency (Student’s t and Fisher’s F 
tests, respectively, with α=0.05 in both cases). 
 
In the most complex cases (models with interactions, see Table 4, Table 5 and Table 6), the 
fitting process involved always a progressive hypotheses of contrast, as it is usual in any 
stepwise multiple regression method, to select the interactive mode providing the most 
statistically consistent interpretation. Parametric confidence intervals, coefficient of multiple 
determination, residual bias and sensitivity analysis were applied as selection criteria. An 
efficient way of proceeding is: 1) calculation of the sigmoidal parameters from the individual 
responses; 2) use of these estimates as provisional fixed values of the model, and assay of 
different interaction hypotheses, rejecting those that lead to not statistically significant 
coefficients; 3) refinement of the model by recalculation, allowing the variation of all the 
accepted parameters. 
 
Although the initial number of parameters is high, it means only a high number of potential 
alternatives, some of which are mutually exclusive, and others easily rejected in the course of 
the fitting to a concrete data set (see again Table 4, Table 5 and Table 6). Trying of initial 
values is facilitated by follow up of the variations produced by the Solver results in graphic 
displays of response surface and residuals, and convergence is usually immediate. Details 
about experimental design are provided as Supporting Information (see Figure A1). 
 
2.2. Null interaction, synergy and antagonism. IA and CA hypotheses 
 
In any system (as defined in the Bertalanffy’s sense: a set of interacting elements), an 
important and characteristic problem is to know whether the joint effect of two or more 
elements on the system behavior is deducible from their individual effects. This issue, with a 
long history of controversy whose first known attempt goes back to Aristotle, is often stated 
by replacing «deducible» with «the sum», what leads to define the notions of synergy and 
antagonism as those interactions by virtue of which the joint effect of two (or more) effectors 
is greater (synergy) or lesser (antagonism) than the sum of the individual effects. 
 
In order to examine the meaning of this non-acceptable statement, let us to consider a system 
in which two effector elements (E1 and E2) can act, and let us to denote the possible 
behaviours or responses of such a system as R1 and R2 (if only E1 or E2 are present), R1,2 (if 
E1 and E2 do not interact), and R1&2 (if E1 and E2 interact). In these conditions it can be 
accepted that any judgment on possible interactions requires to compare R1,2 with R1&2, what 
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leads to define synergy and antagonism, respectively, as those interactions in which R1,2<R1&2 
and R1,2>R1&2. 
 
This implies that the necessary reference to assess any interaction is the response of the 
system in the absence of interactions (the null interaction). Now then, to define the null 
interaction implies, in turn, that any mechanism must be postulated as underlying at any 
concrete behavior of the system. Addition is the simplest mechanism, and its most immediate 
options consist of supposing that the added magnitudes can be the effectors (acting as one 
alone), or the effects on the system of their independent actions (the responses of the system 
to such actions). 
 
Let us suppose now that the response has a superior limit, as it occurs, for example, in the 
case of the death-survival alternative in a microbial population under increasing doses of two 
toxics. If the added magnitudes are the concentrations of the toxics, the response will be, in 
fact –although it can be expressed as a function of two independent variables–, that would be 
obtained with the resulting value as dose of a single toxic. The response addition is more 
problematic, since it is obvious that if one cell dies when one of the doses reaches a given 
level, it will die independently on the level of the other dose, simply because it cannot die 
twice. 
 
These two types of sum are the foundations of the two basic accepted modes for describing 
the joint action of two effectors under null interaction conditions: concentration addition and 
independent action. Although both can be applied –at least in theory– to any number of 
effectors, here will be discussed in their simplest forms, for two effectors (their 
generalizations are, anyway, immediate). 
 
2.2.1. Independent action hypothesis 
It supposes that the effectors act through different mechanisms, whose asymptotic maxima are 
reached through statistically independent phenomena. Under this premise, the probability 
theory allows to define the response as the sum of the probabilities of the individual 
phenomena minus the probability of their joint occurrence [1,8]. Consequently, if Rc is the 
response to the joint action of c1 and c2 concentrations, and Rc1 and Rc2 the individual 
responses at the same concentrations, it can be established: 
 
1 2 1 2c c c cR R R R R= + −  ; or, equivalently: ( )1 2 11c c cR R R R= + −  (1) 
 
An expression easily generalizable to more than two effectors is obtained by writing the first 
Rc1 in the second member of (1) as 1–(1–Rc1): 
 
( ) ( ) ( ) ( )1 2 1 1 2 11 1 1   1 1 1c c c c c cR R R R R R R= − − + − = − − − −     and, finally: 
( ) ( )1 21 1 1c cR R R= − − −  (2) 
 
2.2.2. Concentration addition hypothesis 
In its classical formulation [2,3], null interaction is not defined as a relation between the 
individual responses, but through the following criterion: since the concentration (c) of an 
effector whose action obeys the equation R=f(c) can be considered as a fictitious combination 
of c1 and c2 concentrations (c=c1+c2), it is obvious that the response to c will be described by 
the equation R=f(c), with c=c1+c2. If the response to a mixed dose of two effectors behaves as 
the response to the “mixed” dose of the same effector, it is accepted that the interaction 
 5 
between them is null, implying that any effector concentration can be substituted by the 
equieffective concentration of the other one. 
 
The conventional practice avoids in this case an explicit algebraic formulation for the joint 
response and resorts to the analysis of the isoboles [9], or lines that, on the plane of the 
independent variables, represent the dose combinations that produce an equal response. Thus, 
if D1 and D2 are the doses of two effectors that produce the individual response Ra, and d1 and 
d2 any dose combination that produces the same joint response Ra (Figure 1), under null 
interaction conditions the isobole of the response Ra will be necessarily described by the lineal 
equation: 
 
1 2
1 2
1
d d
D D
+ =  (3) 
 
Consequently, if the individual DR models are Ri=fi(Di) and their reciprocal functions 
Di=gi(Ri) exist, it can be established that: 
 
( ) ( )
1 2
1 2
1  synergy
1  null interaction
>1  antagonisma a
d d
g R g R
<

+ =


 (4) 
 
In other words: straight isoboles indicate null interaction, and concave and convex up isoboles 
indicate synergy and antagonism, respectively. The dimensionless quotients di/gi(Ra) are 
called toxic units and represent the relative contribution of each effector to the joint response 
Ra. 
 
2.3. Some problems associated with the AI-AC approach 
 
A first unsatisfactory aspect of this approach is the difference between the formal criteria 
applied to each mode of action. IA hypothesis proposes an explicit response surface model, 
but a general agreement does not exist about the ways in which synergy and antagonism must 
be formulated. CA hypothesis avoids the explicit model, but equation (4) is accepted as a 
criterion for detecting synergy and antagonism. This criterion, however, is not transferable to 
the IA framework, whose mathematical form prevents straight isoboles in null interaction if –
as it occurs in most DR relationships– the individual responses R1 and R2 are of sigmoidal 
type. As a general rule, IA isoboles in null interaction are convex up at low doses, concave up 
at high doses, and with two branches of opposite curvature in a transitional zone when R1≠R2 
(Figure 1). But the factual meaning of this formal property cannot be attributed to synergy or 
antagonism, only implying that the probability that at least one dose is lethal is low at low 
doses and high at high doses (another outcome of the statistical independence, as the above 
mentioned impossibility of dying twice). 
 
In CA hypothesis, the absence of an explicit model is another disadvantage. A measure of the 
sign and degree in which an isobole deviates from linearity is provided by (4), and isoboles 
with a variable degree of curvature and asymmetry can be defined by using alternative 
expressions as equation (5) described by [10] or equation (6) described by [11]. 
 
( ) ( )
1 2
1 2
1 21 1
1
a a
d d
g R g R
β β
   
+ =      
   
 (5) 
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       
+ + + =              
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 (6) 
 
where the additional parameters β or γ are more precise indexes of synergy and antagonism. 
Although these equations would enable the construction of isobole maps by solving them 
numerically, the procedure is laborious and in practice is usually applied only to the isobole at 
the half-maximum response. Furthermore, in this approach a homogeneous isobolic curvature 
is postulated for the whole of the domain considered, a property which, as we shall see later, 
is not necessarily true. 
 
Some joint responses to chemically similar/dissimilar effectors were suitably described with 
CA/IA models, respectively [12,13]. However, there are evidences, as well, that these modes 
of action are not always obeyed by the reality. Jonker et. al [14] have proposed in each case, 
besides synergy and antagonism, other deviations from null interaction which were defined a 
priori as effects depending on the absolute dose levels or dose ratios, thus enabling 
synergistic and antagonistic displays on different regions of the same response surface. But 
even so, the reality seems to be richer: in a revision of 158 cases, Cedergreen et. al [15] found 
that 20% were adequately predicted only by IA, 10% only by CA, another 20% admitted both 
models and half of the cases were not correctly described with either the two. Moreover, 
neither of the models was significantly better than the other on assessing synergy and 
antagonism at the 50% effective doses. 
 
These results are not, really, surprising. Considering Figure 2, it can be admitted that if the 
toxic action takes place only through the ways k1 and k4 (k2=k3=0), or k2 and k3 (k1=k4=0), the 
model will be IA, and if only through k1 and k3 (k2=k4=0), or k2 and k4 (k1=k3=0), it will be 
CA. But if none of the rate constants is null, the model will be predominantly IA or CA (or 
none of them) depending on the relationships among the ki values. Additional complexities 
can be brought by differences in hindrance mechanisms, selectivity of cell channels or 
conditions of cell dying (individual or simultaneous levels of M1, M2 and M3). In any case, 
IA and CA modes of action are not mutually exclusive alternatives, but ends of a continuum 
or, even preferably, points in a space of possible responses. In our laboratory, these 
ambiguities have been detected not only in the joint action of hydrocarbons and dispersants on 
the larval growth of sea urchin [16], but also, as we will see, in the simpler context of the 
oxidation inhibition of a substrate by the joint action of two antioxidants. 
 
2.4. DR model for a single effector 
 
The natural form of a DR model is a cumulative (mass) probability function, since it translates 
the response of a population with a given distribution of its sensitivity to an effector. Four 
additional conditions seem reasonable as well: 1) the model should have an explicit algebraic 
form; 2) it should be lacking in intercept (null response at null dose); 3) an asymptote equal or 
lesser than 1 should be enabled; 4) the parameters with important factual meaning should be 
explicitly included, to facilitate the trial of initial values and the calculation of confidence 
intervals when non-linear fitting methods are applied. 
 
Although normal and log-normal distributions have been the basis of the classical DR 
analysis, they have the disadvantage of lacking of an explicit form for their cumulative 
functions. Logistic-type equations are more useful and they can be expressed in forms [17,18] 
easily modifiable to comply with the above mentioned conditions. However, their derivatives 
(their density functions) show only right bias, which can be a scarcely realistic restriction. 
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Another option is the Gompertz equation, but its use is prolix, especially with the 
modifications that are required to apply it into the DR context. The cumulative function of the 
Weibull distribution [19] can be expressed in a suitable reparametrized form [20-22] that 
provides the DR model used here:  
 
( ){ }1 exp ln 2 aR K D m = − −   ; briefly: ( ); , ,R W D K m a=  (7) 
 
where D is the dose, R the response (with K as asymptotic maximum, not necessarily 1), m the 
dose producing half-maximum response, and a a shape parameter related to the maximum 
slope of the response (rm) by: 
 
( ) ( )1ln 2 expa Gm
Ka
r G G
m
= −   ; being:   
1a
G
a
−
=  (8) 
 
It should be noted that m is the abscissa of the inflection point, which represents the 
accumulated modal response. The basic parameter of the DR analysis is ED50 or EC50, defined 
as the effective dose for the 50% of the assay population. Thus, m and EC50 are coincident 
values if the maximum response implies the whole population (K=1). The reciprocal function 
of equation (7), which is required for the isobole analysis in CA hypothesis is: 
 
( ){ }
1
ln 1 ln 2 aD m R K= − −    (9) 
 
The use of the equation (7) as DR model is interesting for several reasons. Its density function 
(the distribution of the sensitivity of the population) can be symmetrical or asymmetrical with 
right or left bias, which makes it very versatile. It produced the best fittings, among the above 
mentioned alternatives, when it was applied to the simulations that will be described in the 
next sections, and this result was repeatedly confirmed by experimental data [20,23-26]. 
Finally, the fact that Weibull’s distribution is the conventional model for the failure of 
complex devices makes it attractive, since it unifies phenomena in which a profound analogy 
underlies.  
 
2.5. Simulation of the response to a single effector 
 
Since the basic sigmoidal profile of the DR relationships translates a macroscopic, statistical 
phenomenon, it should be possible to simulate it as a result of the microscopic behavior of a 
population of elementary biological entities, which we will call cells. Such a simulation can 
be carried out on the following basis: 
 
B1. One cell is defined by means of three random magnitudes: ρ, or number of receptors of 
an effector, α, or number of active receptors –ready for linking the effector– in a given 
instant, and λ, threshold or minimum number of active receptors that must be linked to 
effector so that the response takes place. 
B2. The dose D is defined as the number of effector units per cell, accepting that every unit 
is capable of linking to one receptor. 
B3. The cell response r is limited to two modalities: death (r=0) and survival (r=1), obeying 
the following logical rule: 
 
R0:    r = IF(α<λ;1;IF(D<λ;1;0)) 
 
(10) 
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or, as a Boolean proposition (∧ : AND, ∨: OR, ¬ : NO, 1: TRUE, 0: FALSE): 
 
R0:    r = (α<λ)∨(¬ (α<λ)∧ (D<λ)) 
 
Notice that α<λ implies r=1 at any dose. It translates possible limitations in the effector 
bioavailability, resistant cells or other conditions which, relatively frequent in DR 
assays, produce lesser than 1 asymptotes. 
 
Although ρ (highest limit of α) is interesting in some cases, hereafter it will be omitted 
without loss of generality, and a cell will be defined through the pair α, λ. Thus, if we assign 
to α and λ probability distributions defined by their mean and variance values, we can create, 
in a spreadsheet, a virtual cell population whose sensitivity distribution depends on the 
parameters defining α and λ. The population response R to an increasing dose series is 
simulated by applying the rule (10) to each cell and defining R=1–(S/Y) when S cells, of a 
total number Y, survive at a given dose. The typical shape of the response arises even at 
moderate population sizes (Y∼100) and becomes highly stable when Y≥1,000. At low 
population sizes, the variability of the result represents a simulation of the natural variability, 
the experimental error, or both. 
 
These premises define the minimum complexity of a system able to generate a sigmoidal 
response and, despite their schematic character, they produce a great variety of profiles, 
depending on the parameters defining α and λ. Although the microscopic solution of the 
system is determined by such parameters, the obtained profiles can be macroscopically 
described by the conventional equations of the DR analysis. 
 
The use of the Weibull’s distribution for defining α and λ is not essential. With normal, log-
normal, Poisson, binomial, or even uniform distributions, the best descriptions of the 
responses are obtained, as is said, with the model (7). However, distributions with domain 
[0,∞) are obviously preferable, since low means and high variances in (–∞,∞) distributions 
lead to a finite probability of negative values of α and λ, which lacks of physical meaning. 
 
2.6. Simulation of perturbations of the response to an effector 
 
Using the elements above defined, we will admit that a perturbator does not produce a 
response by itself, but it can modify the response to an effector by altering the number of 
active receptors (α), the threshold (λ) or the effective dose corresponding to the nominal dose 
(D) (hereafter α, λ and D-perturbations, respectively). α and D-perturbations can be 
illustrated in molecular terms through the well-known key-lock analogies (Figure 3). λ-
perturbations require to suppose an intermediate fast process modifying the cell sensitivity. 
 
All of them can be exemplified by common physiological mechanisms as those take place in 
trans-membrane proteins, second messengers or enzymatic systems, and any DR assay allows 
to distinguish at least between α and D-perturbations. Indeed, in the presence of an excess of 
effector, a moderate increment of perturbator modifies or not the response depending on 
whether the perturbation acts over the receptors or the effector. 
 
The effect of these perturbations on the response can be simulated by using the rule R0 and 
adding a vector that represents increasing perturbator concentrations, as well as a criterion for 
modifying the values of α, λ or D as a function of the perturbator concentration. Since direct 
or inverse ratios are the simplest criteria, a perturbation term can be formulated as: 
 
 9 
1U p Pε ε= +  ;  (ε = α, λ, D) (11) 
 
where P is the perturbator concentration, pε the proportionality coefficient, and the ε subscript 
indicates the element affected by the perturbation. The term Uε multiplies or divides the 
values of D, α or λ depending on the effect that we are trying to achieve, and it can be 
replaced by any other algebraic expression able to describe any other type of alteration. 
 
Now, it can be pointed out that if a DR curve is sigmoidal because the most sensitive elements 
of a population die at lower doses than the most resistant ones, a time-response curve will be 
sigmoidal if the distribution of the sensitivity of the population is translated into responses at 
shorter or longer times. Although this problem will not be considered here, the time-course of 
the response could be treated also in terms of molecular interactions which, in this case, 
accelerate or delay the progress of the effect (Figure 3). In some fields –e.g. marine toxins–, 
the death time of a target organism replaces often the response in the framework of empirical 
dose-death time models [27-30]. We do not allude here to this approach, but to the time-
response relationships, which can be described by using the same models as DR analysis [25]. 
 
2.7. Simulation of the response to two effectors 
 
In this case, the perturbator must be replaced by a second effector, but the essential issue is 
the need to include in the simulation algorithm, even in the absence of any interaction, any 
rule about the joint action. The simplest hypothesis in this regard leads to admit that: 1) the 
receptors are specific of the effectors; 2) the cell response is r=0 if any of the doses exceeds 
the corresponding threshold and there is a sufficient number of receptors. Thus, the rule is: 
 
R1: r = IF(AND(OR(α1<λ1;D1<λ1);OR(α2<λ2;D2<λ2));1;0) 
 r = ((α1<λ1)∨(D1<λ1))∧ ((α2<λ2)∨(D2<λ2)) 
(12) 
 
These conditions are reminiscent of IA hypothesis and in fact, as we shall see later, they 
produce the typical IA response surfaces. Now then, both conditions can be denied, what 
seems quite reasonable for the second one [31], since it prevents to accept that two biological 
subsystems –e.g. glycolysis and β-oxidation– can be affected at individually sublethal, but 
jointly lethal levels. By denoting the first condition (specificity) as S+ and the second one 
(independence) as I+, three additional rules, besides S+I+, can be considered: 
 
 S
+
I
–. It admits that 1) the effect Gi of a dose Di below threshold λi is Gi=Di/λi; 2) Gi 
values are additive; 3) r=0 if G1+G2≥1 and there enough receptors: 
 
R2: r = IF(Di<αi;IF((D1/λ1+D2/λ2)<1;1;0);IF((α1/λ1+α2/λ2)<1;1;0)) 
 r = (Di<αi)∧ ((D1/λ1+D2/λ2)<1)∨¬ (Di<αi)∧ ((α1/λ1+α2/λ2)<1) 
(13) 
 
 S
–
I
+. It admits that any effector has access to the whole of the receptors (α1+α2), what 
produces competence if they are insufficient. Competence depends on factors as the relative 
doses of the effectors, their diffusivity or their affinity for the receptors, but to simplify, only 
relative doses will be considered here: C1=D1/(D1+D2) and C2=D2/(D1+D2). Thus, the number 
of receptors linked to Di will be Ci(α1+α2), what leads to the rule: 
 
R3: r = IF(ΣDi<Σαi;IF(AND(OR(Σαi<λ1;D1<λ1);OR(Σαi<λ2;D2<λ2));1;0); 
             ;IF(AND(OR(Σαi<λ1;C1(α1+α2)<λ1);OR(Σαi<λ2;C2(α1+α2)<λ2));1;0)) 
 r = (ΣDi<Σαi)∧ ((Σαi<λ1∨D1<λ1))∧ ((Σαi<λ2∨D2<λ2)) ∨ (14) 
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     ∨¬ (ΣDi<Σαi)∧ ((Σαi<λ1∨C1(α1+α2)<λ1))∧ ((Σαi<λ2∨C2(α1+α2)<λ2)) 
 
 S
–
I
–. It admits simultaneously competence (if the receptors are insufficient) and 
additivity of below-threshold effects. The rule is: 
 
R4: r = IF(ΣDi<Σαi;IF(Σ[Di/λi]<1;1;0);IF(Σ[Ci(α1+α2)/λi]<1;1;0)) 
 r = (ΣDi<Σαi)∧ (Σ(Di/λi)<1)∨¬ (ΣDi<Σαi)∧ (ΣCi(α1+α2)/λi<1) 
(15) 
 
None of these rules implies the sum of the doses required by the CA hypothesis. This 
condition plays down the receptor specificity, but again the competence arises if the receptors 
are insufficient. If both effectors have the same threshold, the response is not modified by the 
competence. If the thresholds are different, the number of occupied receptors will depend on 
the relative doses and will be Ci(α1+α2), turning the dose addition effect in below-threshold 
addition effect: Gi=Ci(α1+α2)/λi. Therefore, two rules are possible, any of which produces the 
response surfaces with straight isoboles that characterize the null interaction in the CA 
hypothesis:  
 
R5a: Without competence (equal thresholds): 
 r = IF(AND(Σαi<λ1;Σαi<λ2);1;IF(AND(ΣDi<λ1;ΣDi<λ2);1;0)) 
 r = (Σαi<λ1)∧ (Σαi<λ2)∨¬ ((Σαi<λ1)∧ (Σαi<λ2))∧ (ΣDi<λ1)∧ (ΣDi<λ2) 
(16) 
 
R5b: With competence (different thresholds): 
 r = IF(AND(Σαi<λ1;Σαi<λ2);1;IF(AND(ΣGi<λ1;ΣGi<λ2);1;0)) 
 r = (Σαi<λ1)∧ (Σαi<λ2)∨¬ ((Σαi<λ1)∧ (Σαi<λ2))∧ (ΣGi<λ1)∧ (ΣGi<λ2) 
(17) 
 
2.8. Inherent and accidental mechanisms 
 
Concrete assumptions (about specificities, thresholds, competence and dose or effect addition) 
as those included in the rules R1 to R5 are indispensable for any joint action hypothesis, and 
they represent mechanisms that are inherent to a given null interaction model. Over these 
minimal, inherent modes of action, accidental mechanisms (interactions) can be 
superimposed, in which each effector can perturb the response to each other by modifying the 
number of active receptors, the threshold or the effective dose corresponding to the nominal 
dose. Thus, when the effector E1 perturbs the response to E2, we can write an interaction term 
like (11): 
 
12 2
1U q Dε ε= +  ;  (ε2 = α2, λ2, D2) (18) 
 
which is included into the rules R1 to R5, as a factor or divisor of D2, α2 or λ2. 
 
The interactions can be unidirectional (E1 alters some factor related with E2, but E2 does not 
alter E1 accordingly) or reciprocal (mutual alterations), and these last ones can or cannot be 
symmetrical (the same or different strength in both directions). Whereas the reference of a 
perturbation is the response in the absence of perturbator, the reference of an interaction is the 
inherent mechanism or null interaction. This implies that a given interaction has different 
consequences depending on the inherent mechanism in whose frame it acts. A systematic in 
this regard is proposed in Table 1, which attempts to preserve the main senses of the usual 
terminology [32], and whose categories allow simulations and specific formal descriptions. 
Although this terminology can be used without ambiguity, it seems preferable to simplify it 
by defining stimulation/inhibition as perturbations that increase/decrease the response to an 
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effector, and synergy/antagonism as interactions that increase/decrease the joint response to 
two effectors with respect to the response promoted by the null interaction. 
 
3. RESULTS 
 
3.1. Perturbations of the response to a single effector 
 
Simulations of the response to an effector in the presence of increasing concentrations (P) of a 
perturbator are shown in Figure 4, under the three conditions that depress such a response 
(decrease of the effective dose, decrease of the number of active receptors and increase of the 
threshold). Individual fittings of the resulting profiles to the model (7) proved that, in each 
series, the estimates of K and m parameters varied as a function of P in specific ways (table 
2), thus enabling to identify the underlying perturbation. Although the maximum slope varied 
as a consequence of the variations of K and m, in agreement with (8), the parameter a 
remained constant in all cases. 
 
Such a constancy of a is not surprising, since the simulations with the rule R0 prove that the 
variation of this parameter is related with the variations of the variances of α and λ, a 
condition that was not considered in any case. Such a restriction simplifies the analysis and is 
not arbitrary. From the microscopic point of view adopted for the effector and perturbator 
actions, variations in the number of receptors and threshold are clear possibilities, but it is 
more difficult to justify an action on a population property like the variance. 
 
3.1.1. The perturbation function 
To obtain a simultaneous solution for every series of profiles, an auxiliary function (a 
perturbation function πθ) is required for describing the possible variations of any parameter θ 
as a function of P (Figure 5). This can be achieved by means of different bi-parametric 
(exponential, polynomial or hyperbolic) expressions: 
 
(19) 
(20) 
( )
( ) ( )
2
0
1 1 exp
  1
1 1
b c P
b P c P
b P c P
θ θ θ
θ θ θ θ
θ θ θ
π
θ θ π π
π
 = + −  
= = + +
 = + +
 
(21) 
 
where the θ subscript represents the modified parameter (K, m), θ0 is the parametric value 
when P=0, and the pairs bθ, cθ are fitting coefficients. It should be noted that, in the absence 
of perturbation, the first function requires bθ=0 and cθ=1, whereas the other two require bθ=0 
and cθ=0. Moreover, in the third function the condition cθP = –1 produces a singularity. To 
avoid it, when P is coded in the interval [0,1] it is advisable to include the restriction cθ>–
0.999 in the fitting algorithm. Thus, the model (7) turns into: 
 
[ ]; , ,k mR W D K m aπ π=  (22) 
 
With any of the mentioned forms of πθ, the (22) led to excellent simultaneous fittings, which 
confirmed the specificity of the parametric variations found in the individual descriptions. 
Figure 4 and Table 3 show the results obtained with the hyperbolic function (21), which will 
be the form used now on. The description of the inhibition by ouabain of the hemolytic 
activity of palytoxin [26] illustrates the application of the equation (22) to the perturbations of 
a time-response profile. 
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When the model (22) is satisfied with uni-parametric πθ (bθ=0 or cθ=0), the relationships 
between confidence intervals (CI) and parametric values are approximately of the same 
numerical size in all te cases. When bθ≠0 and cθ≠0 are required, both CI are penalized by the 
linear correlation between both coefficients, and therefore, with high experimental error and 
low number of observations, some bθ, cθ pair can become not statistically significant, even in 
highly predictive models. This problem is solved if the model is recalculated fixing the value 
of one of the coefficients and excluding it of the Student test, or –with a small loss of 
predictive capability– making zero the coefficient of the pair whose suppression does not alter 
the increasing or decreasing trend of the parametric variation due to the perturbation function. 
 
Finally, it is interesting to observe that in D-perturbations two equivalent solutions are 
possible. One of them is that provided by the model (22), describing the variation of m (the 
only affected parameter) due to the presence of the perturbator. The other one describes 
directly the variation of the effective dose through the equation: 
 
[ ]; , ,DR W D K m aπ=  (23) 
 
Later on we will see that this dual solution is not possible in interactions. 
 
3.2. The response surfaces to two effectors 
 
Among the five basic types of response produced by the rules R1 to R5, only two of them 
were in accordance with those corresponding to IA and CA hypotheses, and the diversity 
grew when interactions were included. Two reasons prevent to qualify this diversity as 
lacking in realism: it involves options that are implicit in the same rules that produce IA and 
CA responses, and it translates common physiological mechanisms. In fact, the situation 
seems to be just the opposite one. As Rovati et. al [33] pointed out regarding the cases of 
partial agonist effects, or effectors able to interact with receptors promoting opposite effects, 
there are responses «that were often disregarded by the experimentalists, or considered as 
artifacts, in the absence of a biological and/or mathematical theory to justify them». 
 
It was scarcely surprising that the parametric variations due to interactions showed the same 
specific increasing and decreasing trends as those due to perturbations (table 2), in linear or 
asymptotic forms (Figure 5) depending on quantitative factors. 
 
3.3. Modeling of interactions under the independent action hypothesis 
 
As expected, the response surfaces produced by the rule R1 were consistent with the IA 
hypothesis (Figure 6, Table 4) and could be accurately described by transferring model (7) to 
equation (2): 
 
( ) ( )1 1 1 1 2 2 2 21 1 ; , , 1 ; , ,R W D K m a W D K m a= − − −        (24) 
 
Since each effector can act as perturbator of the response to the other, by altering effective 
doses, active receptors or thresholds, auxiliary functions πθi can be defined in terms as those 
applied to the perturbations. Thus, the (24) will be written, in its most complex form:  
 
( ) ( )1 1 1 1 1 1 2 2 2 2 2 21 1 ; , , 1 ; , ,K m K mR W D K m a W D K m aπ π π π= − − −        
where: ( ) ( )1 1i i j i jb D c Dθ θ θπ = + +   ;  ( ),K mθ =   ;  ( )i j≠  
(25) 
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When this equation was used to describe the corresponding simulations, the specific 
variations in the parameters Ki and mi led to discriminate all the modalities of interaction 
(table 2), whose main types are summarized in Figure 6, Figure 7 and Table 4. In interactions 
affecting the effective dose, the dual solution that is possible in the homologous case of the 
perturbations is reduced here to the option in which the parametric variations affect only to mi. 
 
3.3.1. Partial forms of independent action.  
The rules R2 to R4 combine the three alternatives to the two conditions of R1 that define the 
typical independent action, and the corresponding simulations showed that unspecific 
receptors create a competence which depresses the response, while additive below-threshold 
effects promote a cooperative effect with an opposite enhancing result. Since the equation (1), 
that describes IA mode, contains a term (the product of the individual responses) translating 
the joint probability, it can be supposed that the cooperative and competitive effects could be 
described by including in (1) a coefficient s modifying the contribution of that term. 
 
However, the fitting tests proved that the coefficient s is necessary, but no sufficient, and that 
accurate descriptions (Figure 6) require parametric structures including interaction terms 
(table 4). This seems contradictory with the definitions of inherent mechanism and accidental 
interaction proposed in 2.7, since S+I–, S–I+ and S–I– modes (like IA=S+I+ one) represent 
inherent mechanisms, without modifications of effective doses, receptors or thresholds. 
Nevertheless, the lack of specificity in the receptors and the additivity of the below-threshold 
effects involve that the action of an effector is not indifferent to the presence of the another, 
what constitutes an interaction, although of a passive character. 
 
Thus, a generalized IA model in its most complex form –in practice several πθi=1 are 
expectable–, can be write as: 
 
( ) ( ) ( )[ ]1 1 1 1 1 1 2 2 2 2 2 2 1 1 1 1 1 1; , , ; , , 1 ; , ,k m k m k mR W D K m a W D K m a s W D K m aπ π π π ππ= + − ×  (26) 
 
It should be noted that the need of s≠1 detects the relaxation of some of the conditions 
defining IA mode, but in such a case the identification of possible D, α or λ-interactions 
become confuse. 
 
3.4. Modeling of interactions under the concentration addition hypothesis 
 
As it was said, the application of the CA hypothesis is usually carried out through the isobole 
analysis. However, the definition of null interaction according to Berenbaum provides the key 
for establishing an explicit model. Indeed, if the response to a mixed dose of two effectors 
should behave as a fictitious mixed dose of a single effector, the model is necessarily: 
 
( )1 2 ; , ,R W D D K m a= +    (27) 
 
In fact, the simulations obtained with any of the rules R5 were accurately described by this 
equation, which produced straight isoboles with equal intersection points on the doses axis 
(Figure 8 and Table 5). Although the competence affects the parametric values, it does not 
alter the functional form, making equivalent the two alternatives of the rule R5. 
 
As a consequence of the equation (27), the CA hypothesis can be accepted when the 
individual responses differ in their m parameters and –given the relation (8)– in their 
maximum slopes, but should be rejected when such responses differ in their K parameters. 
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This is consistent with the isobole approach: if the asymptotes differ, expressions as (4), (5) or 
(6) could only be applied to lower responses than the lowest asymptote, since the inverse 
function (9) only exists if R<K. 
 
When interactions are included, the key notion of concentration addition should be preserved 
in any modification of the (27), what means that the doses should act as an additive block in a 
function with a single set of sigmoidal parameters (K, m, a). These conditions enable the cases 
that are described next. 
 
3.4.1. Effectors with different potency.  
This case was simulated by using the rule R5a and multiplying one of the doses by a tox 
factor (tox=1 for effectors with equal potency). Results were fitted –with coded doses in the 
same interval– to the equation: 
 
( )1 2 ; , ,R W uD D K m a= +    (28) 
 
which provided a precise description and produced straight isoboles with different intersection 
points on the doses axis (Figure 8). The u coefficient (u>1 if the first effector has more 
potency than the second one) means that if a joint response is described by the equation (28), 
the m2 parameter of the individual response to the second effector is m2=m×u. 
 
3.4.2. Synergy and antagonism.  
To obtain surfaces with isoboles like those associated with synergy and antagonism, the rule 
R5a must include the condition that an effector alters, unidirectional or reciprocally, the 
effective dose of the other one. By using πDi terms like those πθi defined by equation (22), the 
corresponding simulations (Figure 8 and Figure 9) were described by means of: 
 
( )1 1 2 2 ; , ,D DR W D D K m aπ π= +    (29) 
 
Contrary to the case of the perturbations, the equivalent dual solution based in the variation of 
the m parameter is not possible here. 
 
3.4.3. Interactions effector-receptor (α) and effector-threshold (λ).  
If it is admitted that an effector E1 alters the number of active receptors α2 or the threshold λ2 
of the effector E2, the conservation of the CA hypothesis requires to admit also that E1 alters 
the α1 or λ1 values.  What in turn means to admit auto-inhibitory or auto-catalytic effects. In 
fact, when this type of interactions are included in the rules R5, the response surfaces from the 
resulting simulations are limited by individual responses that decrease after a maximum or 
increase not asymptotically. Moreover, the estimates of the sigmoidal parameters from the 
joint response are only apparent (such as the Michaelian parameters in the presence of 
inhibitors), useful to predict the response surface, but without direct physical meaning in 
connection with individual responses, whose real parameters should be separately calculated 
using the model (7). 
 
Avoiding now to discuss the realism of these behaviors, it can be pointed out that the response 
to lactic acid of some lactic acid bacteria seems to illustrate them, at least in their auto-
inhibitory modality [34-36]. Thus, the response to this acid of Leuconostoc mesenteroides 
[37] showed a profile –like that resulting from an enzymatic kinetics under substrate 
inhibition– which was described by including in the logistic equation a dose-depending term 
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depressing the asymptotic value. But the description is also feasible –and more accurate– 
using a modified Weibull model as:  
 
1
; , ,
1
k i
i
k i
b D
R W D K m a
c D
 +
=  + 
  ;  1
1
0 ;  0 autoinhibition
 
0 ;  0 autostimulation
i
i
b c
b c
= ≠ ⇒

≠ = ⇒
 (30) 
 
In any case, these α and λ interactions under IA response can be described, in their most 
complex forms, by modifying the K and m parameters with interaction terms: 
 
( )1 2 1 2 1 2; , ,k k m mR W D D K m aπ π π π= +    (31) 
 
Although these effects increase or decrease the response with respect to that expected in null 
interaction, the isoboles differ markedly (Figure 9) from those produced by the equation (29) 
and corresponding to synergy and antagonism. 
 
As in IA mode, all the possible options under CA hypothesis can be unified in a generalized 
model which, in its most complex form –again in practice simpler cases with several πθi=1 
should be expected– can be formulates as: 
 
( )1 1 2 2 1 2 1 2; , ,D D k k m mR W u D D K m aπ π π π π π= +    (32) 
 
3.5. Broad and strict sense of the notions of synergy and antagonism 
 
The frequent and not always enlightening discussions about synergy and antagonism have led 
some authors to consider synergy as an «ineffective mixture risk definition» [10]. However, 
we believe that both concepts are important, and that their confused sides can be debugged by 
suppressing some common, not justified assumptions. 
 
Firstly, their formal aspects should be distinguished from the factual ones. From a factual 
perspective, as it has been said, synergy and antagonism are the result of interactions that 
increase or decrease the response with respect to that expected in null interaction. This is a 
broad and unambiguous definition, but it requires taking into account the following issues: 
 
1) Synergistic and antagonistic responses can be generated by any of the interactions (D, α 
or λ) considered in the sections 3.3 and 3.4. This implies that such responses can have 
diverse origins, that these origins require different formal descriptions, and that these 
descriptions are dependent not only on the elements involved in a given interaction, but 
also on the inherent mechanism of the system under null interaction conditions. 
2) Association between concave/convex isoboles and synergy/antagonism is limited and 
misleading. In IA mode, as it has been seen, it lacks sense, and in CA mode it lacks 
general validity. As an example, the reciprocal synergistic α-interaction (Figure 9) 
increases the response in the entire domain with respect to null interaction, in spite of 
which its isoboles are straight. In fact, that association is only applicable to D-interactions 
in CA mode, where the corresponding regular series of concave/convex isoboles enable 
clear contrasts with the straight series which are typical –although no exclusive– of the 
null interaction. 
3) If the usual isobolographic convention in CA framework is followed, synergy/antagonism 
could be defined in a strict sense as those effector-effector interactions that increase / 
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decrease the response. Such a definition, however, would exclude arbitrarily other 
interactions (as α or λ ones) with similar net effects. 
4) Unfortunately, satisfactory expedients for typifying synergy/antagonism by means of a 
single value or a particular isobole do not exist, since the differences between these 
conditions and null interaction vary throughout the corresponding response surfaces 
(Figure 10-C2). 
5) Furthermore, there are not theoretical reasons which prevent interactions with opposite 
regional effects on the response surface (e.g. E1 increases the effective dose of E2, and E2 
increases the parameter m of the response to E1). Consequently, synergy and antagonism 
can be simultaneously detected in different regions throughout a given response surface. 
 
3.6. More insufficiencies and ambiguities of the IA-CA dualism 
 
The frequent inconclusive character of IA and CA hypothesis is a well-documented 
experimental fact [38], whose justification in theoretical terms was suggested in section 2.3. A 
different justification is provided by the simulations described in 2.6 and 3.3.1. Indeed, when 
the conditions that define the IA hypothesis are altered in biologically plausible forms, 
response surfaces with cooperative or competitive effects are obtained, which cannot be 
acceptably described by any of the possibilities of the IA-CA scheme. 
 
An additional cause of ambiguity –difficult to detect in the absence of explicit models– 
derives from a more formal issue. The IA and CA response surfaces are in general clearly 
distinguishable when the asymptotes of the individual responses are less than 1, as in the 
examples of Figure 6-9. But the distinction turns more problematic as these asymptotes move 
closer to 1, since in such a case the IA surface losses its peculiar top region, in which the joint 
response surpasses the asymptotes of the individual responses. Figure 10 shows an IA surface 
obtained by assigning arbitrary parametric values (with K1=K2=1) to the model (1), which 
could be significantly typified as a case of antagonism in CA mode by any assessment 
method, especially if the results are “blurred” by the experimental error. Similarly, a 
reciprocal asymmetrical synergy in IA mode is practically indistinguishable from synergy in 
CA mode. In such cases, the false hypothesis can be only detected by the lack of randomness 
of the residuals, if the number of observations is sufficient and the experimental error is 
reasonable. 
 
All these reasons lead to doubt about the generalization to more than two effectors of any IA-
CA discrimination method, since the probability of all kind of ambiguities increases with the 
number of agents considered. The main justification of this generalization is the experimental 
economy in the research of the joint effect of many effectors at moderate levels, an important 
issue in environmental toxicology, which seems practically unapproachable through the assay 
of binary combinations. However, it seems as well that the simplification of the experimental 
arrays only will produce even more ambiguous results. 
 
3.7. Experimental examples 
 
Some elements of the approach proposed here are exemplified by two above mentioned cases 
of study: the larval growth inhibition in sea urchin by the joint action of hydrocarbons and 
dispersants [16], and the inhibitory perturbation by ouabain of the hemolytic action of 
palytoxin [26]. In fact, the need to clarify problems as those arose in these cases was the 
origin of the simulation-based systematic we have attempted in this work. 
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We present now an experimental example in connection with the antioxidant activity, a field 
in which the possible interactions between both natural and synthetic products are formally 
equivalent to the toxicological ones, and they raise similar discussions. The example refers to 
the inhibition of crocin oxidation by the joint action of two well-known antioxidants: ascorbic 
acid and trolox. Triplicate analytical results were obtained by monitoring of the oxidation 
kinetics in 8×8 concentration arrays, using a microplate method [39,40]. Inhibitory responses 
were quantified through the ratio between areas under kinetic profiles at the end point of the 
control [41-44]. 
 
Antioxidants can compete with the oxidizable substrate for oxygen or the source of radicals 
(primary antioxidants), or for radicalized products that are formed in more advanced oxidation 
phases (secondary antioxidants). Therefore, their modes of action are in agreement with the 
diagrams of Figure 2 and they can be analyzed using the general equations (26) or (32). 
 
In this regard, the example of ascorbic acid and trolox is interesting, because it shows some of 
the features in which a clear decision is difficult (Figure 11 and Table 6). Although null 
interaction cannot be accepted under both IA and CA hypotheses, when a synergistic effect is 
admitted, the difference between the two (statistically significant) options becomes small. 
Residual distribution inclines the decision towards IA, but a more accurate characterization is 
a predominantly independent action, with synergy and a cooperative unspecific effect. On the 
other hand, it should be pointed out that a conventional analysis (use of a model (1) for IA 
hypothesis and a contrast on the 50% isobole for CA hypothesis) would lead to decide a CA  
 
4. DISCUSSION 
The approach we have defended here is supported on three statements: S1) in any algebraic 
macroscopic model, any interaction between effectors is necessarily translated into –
reciprocal or not– modifications of the parametric values describing the individual action of 
each effector. In our modeling, such modifications can adopt increasing or decreasing forms, 
with constant, increasing or decreasing slope in each case; S2) the algorithms used for 
describing microscopic facts underlying common chemical and biological interactions 
produce realistic simulations as long as any hypothetical mechanism considered can be: a) 
defined in terms of levels of effectors, enhancers, inhibitors, receptors and response 
thresholds; b) expressed involving these elements in Boolean propositions; S3) macroscopic 
consequences of all the microscopic mechanisms considered were satisfactorily described by 
the proposed macroscopic modeling. 
 
With these premises, two complementary queries emerge. The first concerns the degree in 
which  the microscopic interactions considered are important for defining observable 
consequences as synergy or antagonism. The second one refers to the possibility that a 
concrete microscopic mechanism can be specifically identified through the macroscopic 
model obtained from a given data set. 
 
Regarding the first query, it can be underlined that the two suppositions in which our 
approach would be insufficient are: 1) parametric variations (with discontinuities, 
singularities, very pronounced inflection points) which cannot be described according to S1; 
2) mechanisms which cannot be reduced, in the last analysis, to the terms S2. Since none of 
these suppositions are too plausible, it can be accepted that the considered interactions are 
considerably relevant –an absolute answer seems impossible in a factual science–, and that, in 
any case, our double approach will help in the search for alternative types of interactions. 
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The second query leads to admit that our modeling is mechanistically in the microscopic-
macroscopic direction, but phenomenological in the opposite one. Therefore, it obeys the 
general fact that none mechanism can be unequivocally deduced from any macroscopic 
description, because different mechanisms can generate the same phenomenological profile. 
In perturbator-effector interactions, a reasonably mechanistic system is possible on the basis 
of the relationships between parametric variations (table 2). But in effector-effector 
interactions, these relations provide only mechanistic suggestions, whose validation requires 
additional experiments as those applied in enzymatic kinetics to the identification of the 
different inhibition modalities. 
 
Nevertheless, our modeling produces explicit algebraic equations able to describe accurately a 
set of situations more diverse and realistic than those considered in other alternatives, and 
allows to classify (at least according to the parametric variations) different modalities of 
synergy and antagonism. The proposed approach solves some recalcitrant and controversial 
aspects of these concepts, as well as the necessary distinction between the factual and formal 
sides of these phenomena, and it exposes several types of theoretical reasons that explain the 
abundance of experimental results that are inconclusive in the IA-CA framework, as it was 
pointed out by other authors [14,38]. These reasons have perhaps diverse origin, but they are 
related, firstly, with the fact that IA and CA hypotheses are far from elemental statements. As 
it is proven by the rules R1 to R4, IA hypothesis involves conditions that can be combined in 
ways that do not obey any of the two modes of action, but whose macroscopic consequences 
can be satisfactorily described in the frame of our proposal. 
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FIGURE CAPTIONS 
 
MAIN MANUSCRIPT: 
 
Figure 1: Isobole of a response Ra. In 1, 2 and 3 the geometric logic underlying the analysis 
of the CA hypothesis through the equation (4) is shown. Type 4 isoboles arise in many real 
responses corresponding to the IA hypothesis with null interaction, and illustrate the 
limitations of the relation between factual and formal aspects of isobole analysis beyond a 
particular case of the CA mode of action (see section 3.5). 
 
Figure 2: A: Hypothetical pathway on which depends the survival of an elementary 
biological entity. It is supposed that: a) the effectors E1 and E2 can hinder the pathway at the 
sites marked as  and ; b) such effectors act with different mechanisms in different Si→Mi 
ways, but with the same mechanism in each way. Under these conditions, the degree in which 
the joint action proceeds according to the IA or CA modes depends on the rate constants k1 a 
k4 ratios (see text). In B, a CA component exist always, which may or may not be combined 
with an IA component. 
 
Figure 3: Some key-lock analogies illustrating the response modifications involving 
alterations of the effective dose or of the number of active receptors (see Table 1). Notice that 
the alterations of the effector-receptor affinity (for reasons of briefness only perturbations are 
illustrated) do not modify the response to a given dose, but the response to a given time. 
 
Figure 4: Effect of a perturbator on the response (R) to a same dose series (D) of an effector 
and the parameters of the model (22). The three cases in which the perturbation depresses the 
response are illustrated: reduction of the effective dose corresponding to the nominal one 
(left), reduction of the number of active receptors (center), and increase of the threshold 
(right). Dots are simulated results in the absence () and presence () of increasing 
concentrations of the perturbator, and lines the respective fittings to the model (22). See also 
Table 2 and Table 3. 
 
Figure 5: Possible variations of a parameter (θ) of the response to an effector, as a function of 
the concentration of a perturbator (P). Any of the functions (19), (20) and (21) can produce all 
the profiles. C, A, L, 0: increasing, asymptotic, decreasing and null variation, respectively, 
increasing (+) or reducing (–) the parametric value. 
 
Figure 6: Joint response to two effectors in the four suppositions resulting from combining 
the two implicit key conditions of the IA hypothesis (see text). In the first column, dots are 
the result of simulations and surfaces the respective fittings to the model (26). Isobolograms, 
correlations between observations and predictions and parametric variations (Ki: , mi: ) of 
the response to an effector as a function of the dose of the another are added. D1 and D2: 
doses; R: response. Numerical data in Table 4. 
 
Figure 7: Some examples of joint responses to two effectors under IA mode of action with 
the specified interactions, adjusted to the generalized model (26). Keys and graphic criteria as 
in Figure 6. 
 
Figure 8: Joint response to two effectors under CA mode of action with the specified 
interactions, adjusted to the generalized model (32). Keys and graphic criteria as in Figure 6. 
See also Table 5. 
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Figure 9: More examples of joint responses to two effectors under CA mode of action with 
the specified interactions, adjusted to the generalized model (32). Keys and graphic criteria as 
in Figure 6. See also Table 5. 
 
Figure 10: A: IA response surface (defined by K1=K2=1.00; m1=m2=0.30; a1= a2=2.00). B: 
result obtained when this surface is interpreted, through CA hypothesis, as a case of 
symmetrical antagonism (K=1.00; m=0.316; a=2.348; cD2=cD1=1.311. All coefficients 
statistically significant, with α=0.05). Notice the residual lack of residual randomness. C: 
differences CA–IA (C1) and CA null interaction–CA antagonism (C2) responses. 
 
Figure 11: Joint effect of ascorbic acid (A1) and trolox (A2) on crocin oxidation under 
different hypotheses. Keys and graphic criteria as in Figure 6, with parametric variations 
replaced by residuals, which are more informative in this case. See details in text, and 
numerical results in Table 6. 
 
SUPPORTING INFORMATION (SI): 
 
Figure A1: Simple radial (A), concentric radial (B), additive (C) and complete (D) designs. 
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TABLES 
 
      
Table 1: A possible systematic on the modifications of the response to an effector. When the modifier 
is a second effector (interactions), unidirectional and reciprocal effects can be considered in every 
case. For details, see text. 
      
      
object of the modification value 
 modifier do not 
promotes response 
(perturbations) 
 modifier is 
another effector 
(interactions) 
      
      
higher  POTENTIATION  SYNERGY effective dose corresponding 
to the nominal dose lower  DEPRESSION  ANTAGONISM 
      
      
higher  STIMULATION  ACTIVATION 
number of active receptors 
lower  INHIBITION  INACTIVATION 
      
      
higher  INSENSITIZATION  ATTENUATION 
threshold 
lower  SENSITIZATION  ENHANCEMENT 
      
 
 
 
          
Table 2: Variations (+: increase; –: decrease; 0: no change) in the parameters  of the response to an 
effector, as described by the equation (7), due to the presence of an agent which produces the 
specified perturbations. Maximum slope, rm, varies according to (8), but the parameter a remains 
constant in all cases. 
          
          
  alteration due to the perturbator 
          
          
  effective dose  active receptors  threshold 
          
          
  higher lower  higher lower  higher lower 
          
          
K  0 0  + –  – + 
m  – +  + –  + – 
          
 
 
 
     
Table 3: Simulation conditions of the responses to an effector as perturbed according to the three 
modalities that cause response drop, and respective fittings to the model (22). r
2
: correlation 
coefficient between observed and predicted results. See also Table 1 and Figure 4. 
     
     
α (mean; sd)  120;48 120;48 120;48 
λ (mean; sd)  80:32 80:32 80:32 
pε↑↓  pD↓=0.006 pα↓=0.006 pλ↑=0.006 
     
     
K  .0.748±0.002 0.756±0.004 0.760±0.005 
m  0.352±0.001 0.353±0.002 0.361±0.003 
a  2.696±0.015 2.685±0.042 2.685±0.045 
     
     
bK  - -0.542±0.013 -0.400±0.028 
cK  - 0.631±0.038 0.671±0.061 
bm  1.198±0.009 -0.385±0.013 0.564±0.030 
cm  - - - 
     
     
adj. r
2 
 0.9999 0.9998 0.9994 
     
Number of active receptors (α) and threshold (λ) are defined by means of aleatory Weibull numbers. Doses and 
perturbator concentrations varie in the natural domain [0-(20)-200] and are coded in the domain [0-(0.1)-1]. pε
coefficients –which operate on natural values of D, α and λ– are those defined in (11).  Arrows indicate increase 
(↑) and decrease (↓) of the affected element. 
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Table 4: Simulation conditions and respective fittings (α=0.05) to the generalized IA model in the specified examples. Active receptors (αi) and thresholds (λi) were 
defined as in Table 3. Doses vary within the natural domain [0-(10)-200] and are coded for fittings within the domain [0-(0.1)-1]. q coefficients defined by (18): a 
notation as D1↓α2 means that the effector E1 reduces the value α2. r
2
: correlation coefficient between observed and predicted results. See also Figure 6-8. 
 
( ) ( ) ( )[ ]1 1 1 1 1 1 2 2 2 2 2 2 1 1 1 1 1 1; , , ; , , 1 ; , ,k m k m k mR W D K m a W D K m a s W D K m aπ π π π π π= + − ×  ;  where: ( ) ( )
1
;  ,
1
 ; i j
i
i j
b D
K m i j
c D
θ
θ
θ
π θ
+
= = ≠
+
 
                  
  S
+
I
+
 (independent action)                      
  null interaction antagonism α-antagonism λ-antagonism S
+
I
–
 S
–
I
+
 S
–
I
–
 
                  
receptors (α1=α2)  120;48 120;48 120;48 120;48 100;40 100;40 95;38 
λ1 threshold  90;36 80;32 80;32 80;32 95;38 95;38 100;40 
λ2 threshold  75;30 80;32 80;32 80;32 95;38 95;38 100;40 
q [D1↑↓D2]  - 0.012 [D1↓D2] - - - - - 
q [D2↑↓D1]  - - - - - - - 
q [D1↑↓α2]  - - 0.01 [D1↓α2] - - - - 
q [D2↑↓α1]         
q [D1↑↓λ2]  - - - 0.01 [ D1↑λ2] - - - 
q [D2↑↓λ1]  - - - - - - -                   
Basic (sigmoidal) parameters K1 0.685±0.002 0.749±0.001 0.750±0.003 0.753±0.002 0.533±0.007 0.935±0.006 0.926±0.005 
of the joint response m1 0.382±0.001 0.352±0.001 0.356±0.002 0.355±0.002 0.368±0.006 0.446±0.003 0.473±0.003 
 a1 2.680±0.027 2.691±0.022 2.661±0.034 2.697±0.034 2.729±0.106 2.667±0.051 2.584±0.047 
 K2 0.780±0.001 0.747±0.002 0.753±0.004 0.752±0.004 0.535±0.007 0.937±0.006 0.925±0.005 
 m2 0.337±0.001 0.351±0.002 0.353±0.002 0.355±0.003 0.369±0.006 0.446±0.003 0.471±0.003 
 a2 2.702±0.022 2.706±0.027 2.657±0.049 2.669±0.053 2.703±0.105 2.658±0.051 2.607±0.048                   
Joint probability factor s 1 1 1 1 1.029±0.005 1.339±0.004 1.054±0.001                   
Perturbations due to D1 bk2 0 0 -0.712±0.042 -0.632±0.067 0 0 0 
modifying the parameters ck2 0 0 0.936±0.085 1.066±0.120 5.971±0.219 0.198±0.025 0 
of the response to D2 bm2 0 2.434±0.031 -0.574±0.033 1.074±0.072 0 0 0 
 cm2 0 0 0 0 5.690±0.265 0 2.684±0.111                   
Perturbations due to D2 bk1 0 0 0 0 0 0 0 
modifying the parameters ck1 0 0 0 0 5.573±0.216 0.193±0.025 0 
of the response to D1 bm1 0 0 0 0 0 0 0 
 cm1 0 0 0 0 6.097±0.274 0 2.792±0.112                   
 r
2
 0.9999 0.9998 0.9996 0.9996 0.9994 0.9994 0.9997                   
Simulation conditions were defined in such a way that produced a typical surface in each case. In S
+
I
+
 (IA) the three basic types of antagonistic unidirectional interactions are shown. 
Parametric structures of synergistic and reciprocal interactions (some examples in Figure 7 and Figure 8) are immediate by symmetry considerations.          
 
 27 
 
 
         
Table 5: Simulation conditions and respective fittings (α=0.05) to the generalized CA model in the specified examples. Notations as in Table 4. See also Figure 9
and Figure 10. 
( )[ ]1 1 2 2 1 2 1 2; , ,D D k k m mR W u D D K m aπ π π π π π= + ; where:  ( ) ( )
1
;      ;  
1
, ,i j
i
i j
i
b D
i j
c D
D K m
θ
θ
θ
π θ
+
= ≠
+
=  
                  
receptors (α1=α2)  80;32 80;32 80;32 80;32 80;32 80;32 60;24 
λ1 threshold  120;48 120;48 120;48 120;48 120;48 120;48 120;48 
λ2 threshold  120;48 120;48 120;48 120;48 120;48 120;48 120;48 
tox (D2)  1 0.7 1 1 1 1 1 
q [D1↑↓D2]  - - 0.02 [D1↑D2] 0.04 [D1↓D2] 0.02 [D1↓D2] - - 
q [D2↑↓D1]  - - 0.02 [D2↑D1] - 0.01 [D2↓D1] - - 
q [D1↑↓α2]  - - - - - 0.004 [D1↓α2] - 
q [D2↑↓α1]  - - - - - 0.001 [D2↓α1] - 
q [D1↑↓λ2]  - - - - - - 0.02 [D1↓λ2] 
q [D2↑↓λ1]  - - - - - - -                   
  null equipotent null non-equipotent  unidirectional recipr. asymm. recipr. receptor recipr. threshold 
  interaction interaction synergy antagonism antagonism modification modification                   
Basic parameters of the K 0.874±0.0006 0.874±0.0006 0.873±0.0004 0.874±0.001 0.874±0.002 0.915±0.007 a 0.700±0.006 a 
joint response m 0.426±0.0007 0.610±0.0013 0.426±0.0009 0.427±0.001 0.426±0.001 0.422±0.002 a 0.390±0.003 a 
 a 2.772±0.0160 2.786±0.0138 2.776±0.0181 2.784±0.016 2.778±0.016 2.850±0.040 a 2.813±0.055 a                   
perturbations due to D1 b2 0 0 7.955±0.075 0 0 0 0 
modifying the actual dose D2 c2 0 0 0 7.986±0.068 4.009±0.024 0 0                   
perturbations due to D2 b1 0 0 0 0 0 0 0 
modifying the actual dose D1 c1 0 0 0 0 2.006±0.012 0 0                   
Relative potency factor u 1 1.428±0.005 1 1 1 1 1                   
Perturbations due to D1 bk2 0 0 0 0 0 0 4.325±0.297 
modifying the common parameters ck2 0 0 0 0 0 0.265±0.008 2.738±0.192 
 bm2 0 0 0 0 0 0 –0.611±0.030 
 bm2 0 0 0 0 0 0 0                   
Perturbations due to D2 bk1 0 0 0 0 0 0 0 
modifying the common parameters ck1 0 0 0 0 0 0.116±0.007 0 
 bm1 0 0 0 0 0 0 0 
 bm1 0 0 0 0 0 0 0                   
 r
2
 0.9999 0.9999 0.9999 0.9998 0.9998 0.9992 0.9994                   
(
a
) apparent parameter (see text). 
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Table 6: Antioxidant joint action of ascorbic acid (A1) and trolox (A2) on crocin oxidation. Hypotheses of null 
interaction and synergy are compared, under the suppositions of independent action and concentration 
addition, through the fitting of the experimental results to the respective generalized models. Adj. r
2
: 
coefficient of multiple determination; res. sk.: residual skewness. See Figure 11 and text for details. 
                          
independent action  concentration addition 
                          
  null interaction synergy    null interaction synergy 
                          
response K1 0,880 ± 0.110 0,830 ± 0.093  joint K 1.021 ± 0.074  0,988 ± 0.019 
to A1 m1 0,150 ± 0.038 0,154 ± 0.039   response m 0.263 ± 0.038 0,304 ± 0.024 
 a1 0,777 ± 0.232 0,667 ± 0.124   a 0.853 ± 0.164  0,663 ± 0.063 
response K2 0,883 ± 0.146 0,922 ± 0.084  relative potency u - - 
to A2 m2 0,260 ± 0.073 0,332 ± 0.057  A1 altering b2D - - 
 a2 1,009 ± 0.286 0,909 ± 0.099  eff. conc. of A2 c2D - - 
A1 as perturbing b2k - -  A2 altering b1D - - 
factor for c2k - -  eff. conc. of A1 c1D - 8.227 ± 2.235 
params. of the b2m - -  A1 as perturbing b2k - - 
response to A2 c2m - 2.619 ± 0.892   factor for c2k - - 
A2 as perturbing b1k - -  params. of the b2m - - 
factor for c1k - -  joint response c2m - - 
params. of the b1m - -  A2 as perturbing b1k - - 
response to A1 c1m - -  factor for c1k - - 
comp / coop s -  0.980 ± 0.038   params. of the b1m - - 
 joint response c1m - - 
adj. r
2
0.951 0.9932   adj. r
2
0.9195 0.9811 
res.sk. -0.827 0.335  res.sk. -0.969 -0.677              
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Figure 11 
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SUPPORTING INFORMATION 
 
Experimental design 
 
In any design, a convenient practice is to code the doses (dividing them by the maximum 
ones) in such a way that both individual series include the same values (Di) within the [0, 1] 
interval. Together with the encoding of the response in the same interval, this facilitates the 
fitting process and provides standardized parametric estimates. Once the Di series is defined, 
there are several reasonable modes to establish the mixed doses covering the experimental 
domain (Figure A1). 
 
Simple radial design: besides the individual series D1i, 0 and D2i, 0 (D1i=D2i=Di), this 
option includes several additional sets of mixed doses (d1i, d2i), each set defined by a constant 
ratio (d1i/d2i=Q) between the concentrations of both effectors. Thus, the mixed dose set 
located along the radius defined by Qn is: 
 
If Qn ≤ 1: [ ]1 ii Qnd D=           ;   [ ]2 i ni Qnd D Q= ×  
If Qn > 1: [ ]1i i nQn
d D Q=     ;   [ ]2 ii Qnd D=  
 
 Concentric radial design: as the preceding one, but with mixed doses defined from the 
angle (ϕn) that each radius makes with the variable representing the D1i series: 
 
[ ] n1i n
= cosid Dϕ ϕ×    ;   [ ] n2i n = sinid Dϕ ϕ×  
 
 Number of radii and values of ϕj (or Q) can be freely fixed, taking into account that 
high (∼75º) and low (∼15º) values of ϕj favour the detection of interactions. 
 
 Equiadditive design: mixed doses are grouped in series defined by a constant sum 
(d1i+d2i=S). Thus, v being the desired number of doses per series: 
 
If Sn ≤ 1: [ ]1 1
n
n vi Sn
S
d S h
v
 
= −  − 
                  ;   [ ] [ ]2 1ni S i Sn n
d S d= −    ;   (hv=0, 1,…v–1) 
If Sn > 1: [ ] ( )1
1 1
1
1
n
n vi Sn
S
d S h
v
− + 
= − +  − 
   ;   [ ] [ ]2 1ni S i Sn n
d S d= −    ;   (hv=0, 1,…v–1) 
 
 Radial equiadditive design: mixed doses fulfil simultaneously the conditions 
d1i/d2i=Qn and d1i+d2i=Sn, therefore: 
 
( )1 1i n nd S Q= +    ;   ( )( )2 1 1 1i n nd S Q = − +   
 
 Complete design: is the most intuitive experimental plan, combining simply all the 
doses of an effector with all doses of the other. 
 
In principle, each design offers specific advantages for identifying concrete modes of action 
and interaction by comparing, through an appropriate statistical criterion, the observed 
responses at certain dose series with the expected ones under IA or CA null interaction 
hypotheses. However, both the simulations with logical rules and those based on the 
  2 
respective explicit models prove that the grounds of this supposition are weak, and its results 
doubtful. Indeed, as it was discussed in 3.5 and 3.6, the response surface properties in joint 
actions imply: 1) numerous indistinguishable situations as analysed by means of radial or 
equiadditive series; 2) responses whose behaviour in a given region of the experimental 
domain does not represent necessarily what takes place in other regions. 
 
In fact, the most discriminative resort is the explicit model, and, for obtaining it, the complete 
design is the most advisable. Even if one wants to disregard doubtful auxiliary functions (see 
below), the responses to a same dose set of an effector in the presence of increasing doses of 
the another form very specific systematic sequences. These sequences are more informative 
than radial or equiadditive ones, and can be advantageously subjected to the comparative 
criteria above mentioned, by using equations (24) and (27), or the responses generated with 
the equations (24) to (31). Additionally, the bootstrap method proves that a good coverage of 
the experimental domain (complete design) is more efficient than an increase of the number 
of replicates to minimize the effects of the experimental error. 
 
 
Figure A1: simple radial (A), concentric radial (B), equiadditive (C) and complete (D) 
designs. 
 
 
